SKU: WN0092 Categories: ,

Recombinant CD141 Fc-Fused Nanobody (VF0392)

$365.00

SKU: WN0092
Enter the quantity you would like, or drag the panel to find the quantity and price that best for you
Bulk QuoteAuthorize OEM & ODM

Product details

Background:The protein encoded byThis intronless gene is an endothelial-specific type I membrane receptor that binds thrombin.This binding results in the activation of protein C, which degrades clotting factors Va and VIIIa and reduces the amount of thrombin generated. Mutations inThis gene are a cause of thromboembolic disease, also known as inherited thrombophilia. [provided by RefSeq, Jul 2008]

Specifications

Size100μL
TargetCD64
ReactivityHuman
ApplicationsFC, ELISA
MW(Calculated)
MW(Observed)45kD
Host Species
IsotypeIgG2a,Kappa
Conjugate/ModificationUnmodified
Recommended Dilution RatioELISA 1:5000-100000; Flow Cyt 1-2μg/Test
FormulationPhosphate-buffered solution
PurificationRecombinant Expression and Affinity purified
Storage-15°C to -25°C/1 year(Do not lower than -25°C)
ConcentrationPlease check the information on the tube
Clonality
Clone NumberVF0024
ImmunogenPurified recombinant Human CD141
SpecificityThis recombinant monoclonal antibody can detects endogenous levels of CD141 protein.
Gene NameTHBD THRM
Protein NameThrombomodulin (TM) (Fetomodulin) (CD antigen CD141)
Other NameThrombomodulin; / TM; / Fetomodulin; / CD antigen CD141
SpeciesHuman
Gene ID2209
UniprotP07204,
Species.1Mouse
Gene ID.114129
Uniprot.1P26151
Species.2
Gene ID.2
Uniprot.2
Cellular LocalizationMembrane; Single-pass type I membrane protein.
Tissue ExpressionMonocyte/macrophage specific.
Signaling_pathwayCellular Processes >> Transport and catabolism >> Phagosome;Organismal Systems >> Immune system >> Hematopoietic cell lineage;Organismal Systems >> Immune system >> Neutrophil extracellular trap formation;Organismal Systems >> Immune system >> Fc gamma R-mediated phagocytosis;Organismal Systems >> Development and regeneration >> Osteoclast differentiation;Human Diseases >> Cancer: overview >> Transcriptional misregulation in cancer;Human Diseases >> Cancer: specific types >> Acute myeloid leukemia;Human Diseases >> Immune disease >> Systemic lupus erythematosus
Research Areas>>Phagosome; / >>Osteoclast differentiation; / >>Neutrophil extracellular trap formation; / >>Hematopoietic cell lineage; / >>Fc gamma R-mediated phagocytosis; / >>Leishmaniasis; / >>Staphylococcus aureus infection; / >>Tuberculosis; / >>Transcriptional misregulation in cancer; / >>Acute myeloid leukemia; / >>Systemic lupus erythematosus
FunctionDisease:Defects in THBD are the cause of thrombophilia due to thrombomodulin defect (THR-THBDD) [MIM:188040]. THR-THBDD is a hemostatic disorder characterized by a tendency to thrombosis.,Thrombomodulin is a specific endothelial cell receptor that forms a 1:1 stoichiometric complex with thrombin. This complex is responsible for the conversion of protein C to the activated protein C (protein Ca). Once evolved, protein Ca scissions the activated cofactors of the coagulation mechanism, factor Va and factor VIIIa, and thereby reduces the amount of thrombin generated.,online information:Thrombomodulin,online information:Thrombomodulin entry,PTM:N-glycosylated.,PTM:The iron and 2-oxoglutarate dependent 3-hydroxylation of aspartate and asparagine is (R) stereospecific within EGF domains.,similarity:Contains 1 C-type lectin domain.,similarity:Contains 6 EGF-like domains.,tissue specificity:Endothelial cells are unique in synthesizing thrombomodulin.,
Please login to post questions
Back to Top
Product has been added to your cart